Indacaterol vs placebo
Quality of life: number of participants with clinically significant improvement (≥ 4 units) in SGRQ total score · patients with chronic obstructive pulmonary disease
Indacaterol leads to higher number of participants with a clinically significant improvement in… compared with placebo (high certainty).
1 finding from 1 review
- Indacaterol, a once‐daily beta₂‐agonist, versus twice‐daily beta₂‐agonists or placebo for chronic obstructive… 2015 · Cochrane Headline outcomes onlyOR 1.649 studies · 4906 participantsHigh